Co-organized by Danielle Swaney and Ruth Huttenhain, QBI and Gladstone Institutes present the 2019 Mass Spectrometry Symposium. Under the leadership of Dr. Nevan Krogan, the Quantitative Biosciences Institute seek transformative results in biomedicine by supporting fundamental quantitative research in the biological sciences. In support of this mission, the 2019 QBI Mass Spectrometry Symposium will focus on emerging proteomic technologies to address outstanding biological challenges.
Ruedi Aebersold, ETH Zurich - "Mass spectrometric exploration of the proteotype"
Josh Coon, University of Wisconsin - "New Technology for Proteomics"
Ben Cravatt, Scripps San Diego - "Activity-based proteomics – protein and ligand discovery on a global scale"
Anne-Claude Gingras, The Lunenfeld-Tanenbaum Research Institute
Albert Heck, Utrecht University - "Quantitative Analysis of Protein Post-translational Modifications and Kinase Activation by Mass Spectrometry"
Jacob Jaffe, Broad Institute - "Proteomic Connectivity Maps for Characterization and Targeting of Drugs"
Don Kirkpatrick, Genentech - "Multiplexed proteomic profiling in basic biology"
Mike MacCoss, University of Washington - "Improving the Comprehensiveness of Targeted Proteomics"
Samuel Myers, Broad Institute - "Genomic Locus Proteomics: The Unbiased Identification of Proteins associated with a Particular Genomic Locus"
Alice Ting, Stanford University - "Proximity labeling for spatial proteomics and transcriptomics"
Judit Villen, University of Washington - "Dynamics and function of the modified proteome"
Tuesday, February 19 at 9:00am to 6:00pm
Gladstone Institutes, Mahley Auditorium 1650 Owens Street, San Francisco, CA 94158